Tatyana N Sokolova

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Positive Breast Cancer

Top Venues

Exploration of targeted anti-tumor therapy

Breast cancer research and treatment

International journal of clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ekatherina Sh Kuligina, Aleksandr A Romanko, Tatjana Jankevic, Aleksandr S Martianov, Alexandr O Ivantsov, Tatyana N Sokolova, Dmitry Trofimov, Aniruddh Kashyap, Cezary Cybulski, Jan A Lubiński, Evgeny N Imyanitov
HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles. Breast cancer research and treatment (2024)
Alexey V Emshanov, Denis V Nesterov, Tatyana N Sokolova, Priscilla S Amankwah, Evgeny N Imyanitov
Unexpected "Lazarus response" to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Alexey V Emshanov, Denis V Nesterov, Tatyana N Sokolova, Priscilla S Amankwah, Evgeny N Imyanitov
Unexpected "Lazarus response" to single-agent bevacizumab in heavily pretreated patients with HER2-positive breast cancer. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Fedor V Moiseyenko, Ekatherina Sh Kuligina, Albina S Zhabina, Sergey A Belukhin, Tatiana A Laidus, Aleksandr S Martianov, Kirill A Zagorodnev, Tatyana N Sokolova, Svetlana A Chuinyshena, Maksim M Kholmatov, Elizaveta V Artemieva, Ekaterina O Stepanova, Tatiana N Shuginova, Nikita M Volkov, Grigoriy A Yanus, Evgeny N Imyanitov
Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer. International journal of clinical oncology 27 (5) (2022)